XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of RSU Activity

The following is a summary of RSU activity under our 2014 EIP and Inducement Plan:

 

 

RSUs

 

 

 

Shares

 

 

Weighted
Average
Grant Date Fair Value

 

Balance as of December 31, 2022

 

 

6,708,608

 

 

$

10.61

 

Granted

 

 

5,278,116

 

 

$

3.71

 

Forfeited

 

 

(669,390

)

 

$

8.63

 

Vested

 

 

(1,554,968

)

 

$

10.74

 

Balance as of June 30, 2023

 

 

9,762,366

 

 

$

6.99

 

Summary of Stock Option Activity

The following is a summary of stock option activity under our 2014 EIP and Inducement Plan:

 

 

Shares

 

 

Weighted Average
Exercise Price

 

 

Weighted Average
Remaining
Contractual Term
(Years)

 

 

Aggregate Intrinsic
Value
(in thousands)

 

Balance as of December 31, 2022

 

 

10,645,555

 

 

$

16.88

 

 

 

6.4

 

 

$

42

 

Granted

 

 

4,693,897

 

 

 

3.64

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(1,522,660

)

 

 

20.95

 

 

 

 

 

 

 

Balance as of June 30, 2023

 

 

13,816,792

 

 

$

11.93

 

 

 

7.6

 

 

$

38

 

Schedule of Common Stock Reserved for Future Issuance Under Equity Incentive Plans

The following shares of common stock were reserved for future issuance under our equity incentive plans as of June 30, 2023:

 

Total Shares
Reserved

 

2014 Equity Incentive Plan

 

22,259,975

 

2018 Inducement Plan

 

4,971,721

 

2014 Employee Stock Purchase Plan

 

332,735

 

Total reserved shares of common stock

 

27,564,431

 

Schedule of Stock-based Compensation, Related to Employee and Nonemployee Stock Awards

Total stock-based compensation expense related to all employee and non-employee stock awards was as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

 

(in thousands)

 

Research and development

 

$

7,195

 

 

$

8,993

 

 

$

13,965

 

 

$

17,499

 

General and administrative

 

 

5,357

 

 

 

5,124

 

 

 

10,351

 

 

 

10,953

 

Total stock-based compensation expense

 

$

12,552

 

 

$

14,117

 

 

$

24,316

 

 

$

28,452